Fact CheckerSign in

NCT07242053Active, not recruiting

Margin Intraoperative CT Feedback Feedback Study

Efficacy of Intraoperative CT Feedback of Wedge Resected Lung for the Assessment of Surgical Margin

Source: ClinicalTrials.gov · Last updated 28 Apr 2026

Brief summary (registry, in English)

To date, there is no established method for confirming whether sufficient margins have been obtained during surgery, only post-surgery by a pathologist. The purpose of this study is to evaluate the impact of intraoperative CT margin feedback on surgical decisions, such as additional removal. The ability to accurately evaluate surgical margins intraoperatively could reduce the risk of locoregional recurrence and eliminate the need for additional treatment after surgery. Moreover, optimal intraoperative feedback to surgeon could influence surgical decision making and contribute to the satisfactory outcome. This is a single center clinical trial. A total of 80 patients scheduled for wedge resections for lung malignancies (including suspected patients) will be enrolled in this study. Nine surgeons in the division of thoracic surgery will also be involved as participants. Once the wedge resection is performed, the resected specimen will be inflated and scanned by CT to measure surgical margin intraoperatively. Surgeons will have access to the CT data and the associated margin data immediately. They then may decide if an additional resection is required. The expected margin surveyed by questionnaire will be compared to CT measured margin, and CT measured margin will be compared to pathological margin questionnaires over course. After the total course of surgery, surgeons will be asked to complete a questionnaire as well to assess the satisfaction by intraoperative feedback.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
80 (estimated)
First submitted
30 Sept 2025
Start date
6 Mar 2024
Primary completion date
1 Aug 2025
Lead sponsor
University Health Network, Toronto
Diseases
Lung cancer
NCT number
NCT07242053

What you commit to

  • Study type: Interventional
  • Planned participants: 80
  • From 6 Mar 2024 to the primary completion date, 1 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Wedge resection for non-therapeutic purpose, e.g. diagnostic purpose.

Other

  • Any patients with inability to give informed consent

Who the study is looking for

  • Patients scheduled for wedge resection for lung malignancies (included suspected lesions).
  • 18 years of age or older.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UHN
Coordinator of this site? Confirm its status
TorontoCanadaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.